Abstract:
Novel 2, 7-di(arylamino)- substituted fluorenes that are further substituted at the 9-position with one or more crosslinkable moieties, oligomers or polymers formed by crosslinking of said crosslinkable moieties, methods for their preparation, and use thereof in forming solvent resistant films having use as interlayers in electronic devices, especially electroluminescent devices.
Abstract:
The present invention provides fluorescent polyfluorene polymers or macromers with unique optical properties that are stable. The polymeric fluorophores are useful in various bioassays formats. The inventive polymers are useful in assays relying on fluorescence resonance energy transfer (FRET) mechanisms where two fluorophores are used.
Abstract:
The present invention relates to novel tetrahydronaphthyl(thio) carboxamides, to processes for preparing these compounds, to compositions comprising these compounds, and to the use thereof as biologically active compounds, especially for control of harmful microorganisms in crop protection and in the protection of materials.
Abstract:
Crosslinkable arylamine compounds; oligomers and polymers prepared from such crosslinkable arylamine compounds; films and coatings; and multilayer electronic devices comprising such films are disclosed.
Abstract:
A novel monoamino compound is provided. Using the monoamino compound, an organic luminescence device is provided, which exhibits a luminescence hue with extremely high purity, and having an optical output of a high luminance with a high efficiency and a long life time. The monoamino compound is represented by the following general formula [1].
Abstract:
The invention provides compounds of formula (I), wherein R and R independently represent H or C1-6 alkyl; R represents phenyl substituted by at least one group selected form halo, CF3, OCF3, CN, OH, C1-6 alkyl and C1-6 alkoxy; and R , R and R independently represent H or -(CH2)n-A, wherein n represents 0, 1 or 2, provided that at least one of R , R and R is other than H; A represents CONR R or SO2NR R , wherein R and R independently represent H, C3-6 cycloalkyl or C1-6 alkyl, the C alkyl group being optionally substituted, in addition, R and R may, together with the N atom to which they are attached, represent a ring which is optionally substituted; CO2R , wherein R represents H or C1-6 alkyl; NR R , wherein R and R independently represent H, C1-6 alkyl (optionally substituted), (C1-6 alkyl)SO2-, (C1-6 alkyl)CO-, H2NSO2- or H2NCO-; a 5- or 6-membered heterocyclic ring containing 1, 2 or 3 heteroatoms selected from N, S and O, which is optionally substituted; S(O)x(C1-6 alkyl), wherein x represents 0, 1 or 2; OH; CN, NO2; or C1-6 alkoxy which is optionally substituted; provided that when NR R represents N(H) methyl, R represents H and R represents 4- chlorophenyl, then R does not represent methoxy; and pharmaceutically acceptable salts thereof. The compounds of the invention are useful in the treatment or prevention of a variety of disorders, including those in which the regulation of monoamine transporter function is implicated.
Abstract translation:本发明提供式(I)化合物,其中R 1和R 2独立地表示H或C 1-6烷基; R 3表示被至少一个选自卤素,CF 3,OCF 3,CN,OH,C 1-6烷基和C 1-6烷氧基的基团取代的苯基; 和R 4,R 5和R 11独立地表示H或 - (CH 2)n A,其中n表示0,1或2,条件是R 4,R 5和 R 11不是H; A表示CONR 6 R 7或SO 2 NR 6 R 7,其中R 6和R 7独立地表示H,C 3-6环烷基或C 1-6烷基,C 1-6 >烷基任选被取代,此外,R 6和R 7可以与它们所连接的N原子一起代表任选被取代的环; CO 2 R 8,其中R 8表示H或C 1-6烷基; NR 9 R 10,其中R 9和R 10独立地表示H,C 1-6烷基(任选取代的),(C 1-6烷基)SO 2 - ,(C 1-6烷基)CO-, H2NSO2-或H2NCO-; 含有1,2或3个选自N,S和O的杂原子的5-或6-元杂环,其被任选取代; S(O)x(C 1-6烷基),其中x表示0,1或2; 哦; CN,NO2; 或任选取代的C 1-6烷氧基; 条件是当NR 1 R 2表示N(H)甲基时,R 4表示H且R 3表示4-氯苯基,则R 5不表示甲氧基; 及其药学上可接受的盐。 本发明的化合物可用于治疗或预防多种疾病,包括涉及单胺转运蛋白功能调节的疾病。